References
- Lohr KH, Harris-Wehling JH. Medicare: a strategy for quality assurance, I: a recapitulation of the study and a definition of quality of care. QRB Qual Rev Bull. 1991;17(1):6–9.
- Brook RH, McGlynn EA, Shekelle PG. Defining and measuring quality of care: a perspective from US researchers. Int J Qual Health Care. 2000;12(4):281–95.
- Vliet Vlieland TP, Huizinga TW. Quality indicators in rheumatology: valid for whom? Ann Rheum Dis. 2009;68(12):1797–9.
- Campbell SM, Roland MO, Buetow SA. Defining quality of care. Soc Sci Med. 2000;51(11):1611–25.
- Campbell SM, Braspenning J, Hutchinson A, Marshall MN. Research methods used in developing and applying quality indicators in primary care. BMJ. 2003;326(7393):816–9.
- Yazdany J, Panopalis P, Gillis JZ, Schmajuk G, MacLean CH, Wofsy D, et al. A quality indicator set for systemic lupus erythematosus. Arthritis Rheum. 2009;61(3):370–7.
- Quinzanos I, Davis L, Keniston A, Nash A, Yazdany J, Fransen R, et al. Application and feasibility of systemic lupus erythematosus reproductive health care quality indicators at a public urban rheumatology clinic. Lupus. 2015;24(2):203–9.
- MacLean CH, Saag KG, Solomon DH, Morton SC, Sampsel S, Klippel JH. Measuring quality in arthritis care: methods for developing the Arthritis Foundation’s quality indicator set. Arthritis Rheum. 2004;51:193–202.
- Fitch K, Bernstein SJ, Aguilar MD. The RAND/UCLA appropriateness method user’s manual. Santa Monica, CA: RAND; 2001.
- Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q. 1966;44(3):Suppl:166–206.
- Bertsias G, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostal C, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis. 2008;67(2):195–205.
- Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Cervera R, et al. Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. Autoimm Rev. 2011;10(7):383–8.
- Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, et al. EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017;76(3):476–85.
- Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012;71(11):1771–82.
- Ruiz Irastorza G, Espinosa G, Frutos MA, Jimenez Alonso J, Praga M, Pallares L, et al. Diagnosis and treatment of lupus nephritis. Consensus Document from the Systemic Auto-Immune Disease Group (GEAS) of the Spanish Society of Internal Medicine (SEMI) and Spanish Society of Nephrology (S.E.N.). Nefrologia. 2012;32:1–35.
- Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, et al. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis. 2010;69(7):1269–74.
- Zhan C, Miller MR. Administrative data based patient safety research: a critical review. Qual Saf Health Care. 2003;12:ii58–63.
- Johantgen M, Elixhauser A, Bali JK, Goldfarb M, Harris DR. Quality indicators using hospital discharge data: state and national applications. Jt Comm J Qual Improv. 1998;24(2):88–105.
- Farquhar M. AHRQ Quality Indicators. In: Hughes RG, editor. Patient Safety and Quality: An Evidence-Based Handbook for Nurses. Chapter 45. Rockville, MD: Agency for Healthcare Research and Quality; 2008.
- Fukuma S, Shimizu S, Niihata K, Sada KE, Yanagita M, Hatta T, et al. Development of quality indicators for care of chronic kidney disease in the primary care setting using electronic health data: a RAND-modified Delphi method. Clin Exp Nephrol. 2017;21(2):247–56.
- Tonner C, Schmajuk G, Yazdany J. A new era of quality measurement in rheumatology: electronic clinical quality measures and national registries. Curr Opin Rheumatol. 2017;29(2):131–7.
- Yazdany J, Myslinski R, Miller A, Francisco M, Desai S, Schmajuk G, et al. Methods for developing the American college of Rheumatology’s electronic clinical quality measures. Arthritis Care Res (Hoboken). 2016;68(10):1402–9.
- Yazdany J, Robbins M, Schmajuk G, Desai S, Lacaille D, Neogi T, et al. Development of the American College of Rheumatology’s rheumatoid arthritis electronic clinical quality measures. Arthritis Care Res (Hoboken). 2016;68(11):1579–90.
- Yazdany J, Trupin L, Schmajuk G, Katz PP, Yelin EH. Quality of care in systemic lupus erythematosus: the association between process and outcome measures in the Lupus Outcomes Study. BMJ Qual Saf. 2014;2:659–66.
- Chassin MR, Loeb JM, Schmaltz SP, Wachter RM. Accountability measures–using measurement to promote quality improvement. N Engl J Med. 2010;363(7):683–8.
- Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care. 2003;15(6):523–30.
- Schmajuk G, Yelin E, Chakravarty E, Nelson LM, Panopolis P, Yazdany J. Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators. Arthritis Care Res. 2010;62(7):993–1001.